Gili Kenet
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 241 publications
A Fragile Balance: Combined Thrombosis and Bleeding Disorders in Neonates.
Journal: Seminars in thrombosis and hemostasis
Published: May 14, 2026
Antiphospholipid syndrome in the paediatric population: performance of ACR-EULAR classification criteria in a controlled cohort.
Journal: Lupus science & medicine
Published: February 16, 2026
Outcomes in venous thromboembolism with retained vs removed inferior vena cava filters: an analysis from the Registro Informatizado de Enfermedad TromboEmbólica.
Journal: Research and practice in thrombosis and haemostasis
Published: December 20, 2025
Spinal Cord Infarct in Children: A Decade of Experience From a Tertiary Referral Center.
Journal: Pediatric blood & cancer
Published: December 10, 2025
Spinal Cord Infarct in Children: A Decade of Experience From a Tertiary Referral Center.
Journal: Pediatric blood & cancer
Published: December 10, 2025
Deleterious NKAP Mutations Are Associated with Musculoskeletal Abnormalities in Hemizygous Males and Skewed X Chromosome Inactivation in Heterozygous Females.
Journal: International journal of molecular sciences
Published: November 30, 2025
Challenges in Balancing Hemostasis and Thrombosis in Therapy Tailoring for Hemophilia: A Narrative Review.
Journal: International journal of molecular sciences
Published: November 26, 2025
FVIII exposure, bleeding outcomes, and inhibitor development in 80 PUPs and MTPs with severe hemophilia A on emicizumab prophylaxis: real world data from the PedNet Registry.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 06, 2025
Inhibitor development according to FVIII concentrates in previously untreated patients with severe hemophilia A: update from the PedNet registry.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 04, 2025
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results.
Journal: Research and practice in thrombosis and haemostasis
Published: October 02, 2025
Last Updated: 09/26/2026